A method for non-invasive genotyping of APCmin/+ mice using fecal samples by Symonds, Erin L & Fenech, Michael
METHODOLOGY Open Access
A method for non-invasive genotyping of APC
min/+
mice using fecal samples
Erin L Symonds




min/+ mouse is commonly used in cancer research and is just one of many genetically altered models that
is currently being developed. With high numbers of breeding programs, it is important to have a simple method
that can be used to genotype the mice non-invasively. Here we report a reproducible method for genotyping
mice with DNA extracted from fecal samples. Comparison of fecal results with those obtained from intestinal tissue
DNA and clinical outcome (presence/absence of tumors) showed this technique to have 100% accuracy. This non-
invasive method of genotyping may be applied to other transgenic mouse models.
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Introduction
With advances in molecular genetics, there are large
numbers of transgenic and knock-out mice being devel-
oped. The most common method for genotyping these
mice is with DNA isolated from tail, ear or toe tissue, or
from blood. These collection techniques however are
invasive procedures and are not appropriate for repeat
sampling. Recent publications have shown that DNA
can be isolated from fecal samples, which allows for
non-invasive genotyping [1,2].
In this work we describe a method for genotyping
APC
min/+ and wild-type mice with DNA isolated from
fecal pellets. The APC
min/+ mouse is a model for familial
adenomatous polyposis, with the mice highly susceptible
to spontaneous intestinal adenoma formation at an early
age, and anaemia as a secondary condition [3]. This
mouse model is therefore commonly used in cancer
research. It has a chemically-induced dominant muta-
tion (base substitution mutation) in the adenomatous
polyposis coli (APC) gene which is considered a tumor
suppressor gene [4]. It has been shown that the main
mechanism for tumor induction is loss of the wild-type
(Apc+) allele (ie. loss of heterozygosity) [5,6].
The aims of this study were to assess the sensitivity,
specificity and reproducibility of genotyping APC
min/+
mice and their wild-type littermates with DNA isolated
from their fecal samples.
Results and discussion
This study has shown that APC
min/+ mice and their
wild-type litter mates (> 3 wk) can be genotyped using
DNA isolated from whole fecal samples without the
need for isolation of the colonic cells from the rest of
the fecal mass. The collection technique is non-invasive
to the mouse and therefore repeatable. Fecal pellet col-
lection from mice aged greater than 3 wk was very sim-
ple, with the majority of mice providing a sample within
1 min. Collection of feces from mice younger than the
weaning age (3 wk) was difficult due to their milk diet,
and resulted in a poor DNA yield as the sample was
small. DNA extraction from a mouse (> 3 wk) fecal pel-
let resulted in a yield of 20 - 350 ng/μL (average 75 ± 4
ng/μL (mean ± standard error)), and a purity (deter-
mined with the nanodrop OD260:OD280) of 2.02 ± 0.01.
Following successful amplification of the DNA, running
the PCR products on the gel allowed the determination
of the genotype of the mouse.
To determine the accuracy of the genotyping with
fecal samples, 28 wild-type and 28 APC
min/+ mice were
genotyped with both fecal and small intestinal tissue
DNA samples. There was 100% agreement between the
results (Table 1). Another validation of the genotyping
results was completed by the presence or absence of
small intestinal tumors in wild-type and APC
min/+ mice
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min/+ with
the fecal DNA samples were found to have tumors in
their small intestine at age 13 wk, compared to none of
the wild-type mice (Table 1). This validation shows
100% sensitivity and specificity of the genotyping.
The reproducibility of the genotyping with fecal sam-
ples was assessed by collecting and analyzing DNA from
fecal pellets from mice on multiple occasions (with at
least one week between collections). All samples gave
the same genotype every time tested, showing the
method to be reproducible (data not shown).
Methods
APC
min/+ and wild-type (APC
+/+)m i c ew e r ep r o d u c e d
in a breeding program that involved mating male APC-
min/+ (Jackson Laboratories, Bar Harbor, ME) with
female C57BL/6 mice (ARC, Perth, Australia). All meth-
ods were approved by the CSIRO animal ethics commit-
tee (Adelaide, South Australia).
DNA isolation
Fresh fecal samples were collected from the offspring
(aged 3 - 13 wk) by placing the mouse in an empty cage
until a pellet was passed. One fecal pellet per mouse was
adequate for analysis. The DNA was isolated while the
sample was fresh using the Qiagen Blood and Tissue Kit
(Qiagen, Victoria, Australia). Briefly, 180 - 380 μL tissue
lysis buffer was added to the fecal sample (depending on
the size) along with 20 μL proteinase-K. The sample was
incubated at 55°C for 2.5 h (vortexed every 45 min), fol-
lowed by the addition of a further 200 μL lysis buffer. This
resulted in the majority of the fecal pellet being dissolved
and filtering of the sample was not performed. The DNA
was precipitated with ethanol and purified with the Qiagen
spin column according to the manufacturer’s instructions.
DNA was eluted in 100 μL AE buffer and quantified with
a nanodrop (NanoDrop Technologies, Wilmington, DE).
A sub-group of mice aged 13 wk were culled and small
intestinal tissue was collected and stored at -80°C. DNA
was isolated from the tissue following the above protocol,
b u tt h et i s s u ew a sf i r s tl y s e di n1 8 0μLt i s s u el y s i sb u f f e r
with 20 μL proteinase-K overnight at 36°C.
Genotyping
For each DNA sample, real-time PCR was set up con-
taining three primers (a specific primer for wild-type
and APC
min and a common antisense primer; Table 2
[7]) to detect each allele. Real time PCR was done in a
final volume of 20 μL/sample, using 10 μLS Y B R
®
Green PCR Master Mix (Applied Biosystems, Victoria,
Australia), 0.25 μL wild-type primer, 0.25 μLA P C
min
primer, 0.5 μL common antisense, and 40 ng DNA. A
negative PCR control contained all reagents except
DNA. Real time PCR was performed using the Applied
Biosystems 7300 Real-Time PCR System, with the fol-
lowing cycling conditions: 10 min at 95°C, followed by
40 cycles of 95°C for 30 sec, 55°C for 30 sec, and 72°C
for 1 min. The dissociation stage was performed by 95°
C for 15 sec, 55°C for 30 sec, and 95°C for 15 sec. PCR
products were run on 2% (w/v) agarose gel in 0.5 ×
TAE buffer (Tris, acetic acid, ethylenediaminetetraacetic
acid) containing gel red (Jomar Diagnostics, Stepney,
South Australia). Wild-type mice had a single band (619
bp), while APC
min/+ m i c eh a dt w ob a n d s( 3 3 1b pa n d
619 bp, Figure 1)
Analysis
Fecal genotyping results were assessed for sensitivity and
specificity by comparing the results to those obtained
from intestinal tissue DNA, and to the presence or
absence of intestinal tumors in mice. The reproducibility
of the fecal genotyping technique was assessed by col-
lecting additional fecal pellets from mice, with at least
one week between collections. Fecal samples were col-
lected from wild-type (n = 21) and APC
min/+ mice (n =
29) on two to eleven occasions and analyzed for
genotype.
Conclusions
In conclusion, this technique is suitable for genotyping
APC
min/+ mice and their wild-type littermates. The gen-
otype results using fecal DNA were consistent with that
found from DNA isolated from small intestinal tissue,
and also consistent with the presence or absence of
intestinal tumors. It is a simple and reproducible test
Table 1 Comparison of fecal genotyping result to other methods
Genotype determined from fecal DNA
Alternative technique Wild-type APC
min/+
Presence of intestinal tumors 0/40 40/40
Intestinal tissue genotype positive for wild-type 28/28 0/28
Intestinal tissue genotype positive for APC
min/+ 0/28 28/28
Table 2 Polymerase chain reaction primers [7]
Primer Sequence
Wild-type 5’ GCC ATC CCT TCA CGT TAG 3’
APC
min 5’ TTC TGA GAA AGA CAG AAG TTA 3’
Common antisense 5’ TTC CAC TTT GGC ATA AGG C 3’
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mouse models. Its non-invasive nature will reduce phy-
sical injury and anxiety of the mouse which will improve
animal welfare.
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Figure 1 Genotyping of APC
min/+ mice with fecal DNA. Analysis
of PCR products with agarose gel electrophoresis, showing products
of the predicted sizes (Lane 1- 100 bp ladder; Lane 2- 20 bp ladder;
Lane 3 and 4- PCR products from mice with the wild-type allele,
619 bp; Lane 5 and 6- PCR products from mice with the APC
min/+
allele, 619 bp and 331 bp).
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